2 Pharma Stocks You Can Buy and Hold for the Next Decade
In the past 10 years, the pharmaceutical industry's performance has lagged well behind that of the broader market. The SPDR S&P Pharmaceutical Index ETF, an industry benchmark, is up by 107% in the past decade, less than half what the S&P 500 has returned in the same period. What's the reason behind this poor showing? It could be that investors are worried about a complete overhaul of the entire healthcare industry, which has been the goal of several prominent U.S. politicians.
Or perhaps the backlash some drugmakers have experienced regarding their pricing practices has some investors running for the hills. That said, the pharmaceutical industry remains an excellent place to look for quality stocks to buy. Two pharma giants worth adding to your portfolio are Pfizer (NYSE: PFE) and AstraZeneca (NASDAQ: AZN). Here's why these two drugmakers are worth holding onto for the next decade.
Image source: Getty Images.
Source Fool.com